These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 23846454)
21. Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines? Tomaszuk-Kazberuk A; Kozuch M; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Musial WJ Ren Fail; 2013; 35(2):235-42. PubMed ID: 23176538 [TBL] [Abstract][Full Text] [Related]
22. [Manifestation and prevention of adverse drug reactions (ADR) in the pharmacotherapy of cardiovascular diseases]. Teweleit S; Kuschel U; Hippius M; Goettler M; Bornschein B Med Klin (Munich); 2001 Aug; 96(8):442-50. PubMed ID: 11560044 [TBL] [Abstract][Full Text] [Related]
23. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Komajda M; Follath F; Swedberg K; Cleland J; Aguilar JC; Cohen-Solal A; Dietz R; Gavazzi A; Van Gilst WH; Hobbs R; Korewicki J; Madeira HC; Moiseyev VS; Preda I; Widimsky J; Freemantle N; Eastaugh J; Mason J; Eur Heart J; 2003 Mar; 24(5):464-74. PubMed ID: 12633547 [TBL] [Abstract][Full Text] [Related]
24. Treatment of Cardiovascular Diseases Among Elderly Residents of Long-term Care Facilities. Kańtoch A; Gryglewska B; Wójkowska-Mach J; Heczko P; Grodzicki T J Am Med Dir Assoc; 2018 May; 19(5):428-432. PubMed ID: 29402648 [TBL] [Abstract][Full Text] [Related]
25. Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders. Siwek M; Woroń J; Gorostowicz A; Wordliczek J Pharmacol Rep; 2020 Apr; 72(2):350-359. PubMed ID: 32124390 [TBL] [Abstract][Full Text] [Related]
26. [Drugs used in cardiovascular diseases and cytokines]. Andrzejczak D; Górska D Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270 [TBL] [Abstract][Full Text] [Related]
27. The impact of cardiovascular drugs on the efficacy of local anesthesia in dentistry. Milosavljevic МJ; Jankovic SM Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):571-577. PubMed ID: 27485183 [TBL] [Abstract][Full Text] [Related]
28. [Cardiovascular pharmacotherapy in old age: How beneficial is it? What does it cost?]. Gysling E Praxis (Bern 1994); 1995 Oct; 84(44):1248-51. PubMed ID: 7491446 [TBL] [Abstract][Full Text] [Related]
30. Cardiovascular medications and risk of cancer. Ocampo NV; Tafreshi J; Hauschild CL; Pai RG Am J Cardiol; 2011 Oct; 108(7):1045-51. PubMed ID: 21784384 [TBL] [Abstract][Full Text] [Related]
31. Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease. Sanal S; Aronow WS J Gerontol A Biol Sci Med Sci; 2003 Nov; 58(11):1046-8. PubMed ID: 14630888 [TBL] [Abstract][Full Text] [Related]
32. Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population. Patten SB; Williams JV; Love EJ Can J Psychiatry; 1996 Sep; 41(7):469-76. PubMed ID: 8884037 [TBL] [Abstract][Full Text] [Related]
33. Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy. Imprialos KP; Stavropoulos K; Doumas M; Tziomalos K; Karagiannis A; Athyros VG Curr Vasc Pharmacol; 2018 Jan; 16(2):130-142. PubMed ID: 28595561 [TBL] [Abstract][Full Text] [Related]
34. [Validity of cardiovascular prescriptions to the guidelines in the elderly according to the STOPP and START method]. Coupet M; Renvoize D; Rousseau C; Fresil M; Lozachmeur P; Somme D Geriatr Psychol Neuropsychiatr Vieil; 2013 Sep; 11(3):237-43. PubMed ID: 24026128 [TBL] [Abstract][Full Text] [Related]
35. [Impact of cardiac drug intake on adaptation to high temperatures in patients with cardiovascular diseases under conditions of the abnormally hot summer of 2010]. Ageev FT; Smirnova MD; Svirida ON; Kuzmina AE; Shatalina LC Ter Arkh; 2013; 85(3):63-9. PubMed ID: 23720845 [TBL] [Abstract][Full Text] [Related]
36. Drug-drug interactions among elderly patients hospitalized for drug toxicity. Juurlink DN; Mamdani M; Kopp A; Laupacis A; Redelmeier DA JAMA; 2003 Apr; 289(13):1652-8. PubMed ID: 12672733 [TBL] [Abstract][Full Text] [Related]
37. Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study. Lopez-Carmona D; Bernal-Lopez M; Mancera-Romero J; Jansen-Chaparro S; Portales-Fernandez I; Baca-Osorio AJ; Perez-Gonzalez R; Tinahones FJ; Gomez-Huelgas R Eur J Prev Cardiol; 2012 Oct; 19(5):1074-81. PubMed ID: 21810843 [TBL] [Abstract][Full Text] [Related]
38. Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect? Ishani A; Herzog CA; Collins AJ; Foley RN Kidney Int; 2004 Mar; 65(3):1017-25. PubMed ID: 14871422 [TBL] [Abstract][Full Text] [Related]